HEALIONICS

From the company

Healionics is developing safer, more reliable vascular access solutions to enhance the health and longevity of kidney failure patients while reducing the high cost of dialysis care. Its STARgraft vascular graft has demonstrated superior resistance to occlusion and infection in human studies and has been granted Breakthrough Device designation by the FDA. STARgraft leverages Healionics' STAR (Sphere Templated Angiogenic Regeneration) biomaterial scaffold, a synthetic biomaterial designed to enable angiogenesis and healing while reducing foreign body respo